Director/PDMR Shareholding
Summary by AI BETAClose X
Notification and public disclosure of transactions by persons discharging managerial responsibilities ('PDMR') and persons closely associated with them ('PCA')
In accordance with the Company's fee structure for its Non-Executive Directors, the following numbers of Ordinary Shares of 1p each (the 'Shares') in the capital of the Company were purchased on 13 March 2026. The total holding and total percentage holding of each Director following notification of these transactions are included below:
|
Name of Director |
Number of Shares Purchased |
Purchase Price per Share (GBP) |
Shareholding following the transactions |
Percentage of Issued Share Capital % |
|
Andrew Martin |
485 |
37.94 |
9,841 |
0.00639% |
|
|
|
|
|
|
|
Hilde Merete Aasheim |
156 |
37.94 |
156 |
0.00010% |
|
|
|
|
|
|
|
Graham Allan |
156 |
37.94 |
3,114 |
0.00202% |
|
|
|
|
|
|
|
Gurnek Bains |
156 |
37.94 |
1,107 |
0.00072% |
|
|
|
|
|
|
|
Robin Freestone |
156 |
37.94 |
9,212 |
0.00598% |
|
|
|
|
|
|
|
Tamara Ingram |
151 |
37.94 |
737 |
0.00048% |
|
|
|
|
|
|
|
Jez Maiden |
138 |
37.94 |
749 |
0.00049% |
|
|
|
|
|
|
|
Steve Mogford |
156 |
37.94 |
277 |
0.00018% |
|
|
|
|
|
|
|
Apurvi Sheth |
156 |
37.94 |
395 |
0.00026% |
|
|
|
|
|
|
|
Jean-Michel Valette |
154 |
38.84 |
11,116 |
0.00722% |
This announcement, including the notifications below, is made in accordance with DTR 3.1.2-A, incorporating article 19(1) of the Market Abuse Regulation.
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||||||||||||||||||||||||||||||||||
|
a) |
Name |
1. Andrew Martin 2. Hilde Merete Aasheim 3. Graham Allan 4. Gurnek Bains 5. Robin Freestone 6. Tamara Ingram 7. Jez Maiden 8. Steve Mogford 9. Apurvi Sheth 10. Jean-Michel Valette
|
|||||||||||||||||||||||||||||||||
|
2 |
Reason for the notification |
||||||||||||||||||||||||||||||||||
|
a) |
Position/status
|
1. Chairman and PDMR 2. Non-Executive Director and PDMR 3. Senior Independent Non-Executive Director and PDMR 4. Non-Executive Director and PDMR 5. Non-Executive Director and PDMR 6. Non-Executive Director and PDMR 7. Non-Executive Director and PDMR 8. Non-Executive Director and PDMR 9. Non-Executive Director and PDMR 10. Non-Executive Director and PDMR |
|||||||||||||||||||||||||||||||||
|
b) Initial notification Initial notification /Amendment |
|||||||||||||||||||||||||||||||||||
|
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||||||||||||||||||||||||||||
|
a) Name Intertek Group plc |
|||||||||||||||||||||||||||||||||||
|
b) LEI 2138003GAT25WW1RN369 |
|||||||||||||||||||||||||||||||||||
|
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||||||||||||||||||||||||||||
|
a) Description of the Ordinary 1p shares financial instrument, type of instrument Identification code ISIN: GB0031638363 |
|||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||
|
c) Price(s) and volume(s)
|
|||||||||||||||||||||||||||||||||||
|
d) Aggregated information
|
|||||||||||||||||||||||||||||||||||
|
e) Date of the 2026-03-13 transaction |
|||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||
For further information in respect of this announcement please contact:
Ida Woodger, Group Company Secretary +44 (0)207 396 3475
Date of notification: 16 March 2026
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 52 minutes ago Prudential
- 1 hour ago Vanquis Banking Group 20
- 3 hours ago Frasers Group
- 3 hours ago Cavendish Financial
- 3 hours ago Diaceutics